Home Cart Sign in  
Chemical Structure| 1061318-81-7 Chemical Structure| 1061318-81-7

Structure of Debio 0932
CAS No.: 1061318-81-7

Chemical Structure| 1061318-81-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Debio 0932 (CUDC-305) is an orally available HSP90 inhibitor with IC50 values of 100 nM and 103 nM for HSP90α and HSP90β, respectively.

Synonyms: CUDC-305

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Debio 0932

CAS No. :1061318-81-7
Formula : C22H30N6O2S
M.W : 442.58
SMILES Code : NC1=NC=CC2=C1N=C(SC3=C(N(C)C)C=C(OCO4)C4=C3)N2CCNCC(C)(C)C
Synonyms :
CUDC-305
MDL No. :MFCD18633209

Safety of Debio 0932

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of Debio 0932

DNA

Isoform Comparison

Biological Activity

Description
Debio 0932 (CUDC-305) is an orally active inhibitor of HSP90, exhibiting IC50 values of 100 nM for HSP90α and 103 nM for HSP90β [1].

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01168752 Cancer|Neoplasms|Solid Tumors|... More >>Lymphoma Less << PHASE1 COMPLETED 2025-04-13 Centre Georges-Fran?ois Lecler... More >>c, Dijon, 21079, France|Institut Claudius Regaud, Toulouse, 31052, France|Institut Gustave Roussy, Villejuif, 94805, France Less <<
NCT03675542 Psoriasis Vulgaris PHASE1 UNKNOWN 2020-02-01 Aarhus University Hospital, Aa... More >>rhus, 8200, Denmark Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.26mL

0.45mL

0.23mL

11.30mL

2.26mL

1.13mL

22.59mL

4.52mL

2.26mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories